Archive Newsletter
-
10.06.26 -- Structuring CGT Deals For The Long Term With Troutman Pepper Locke's EA Weeks, J.D., Ph.D.
10/6/2026
10/06/26 Cell & Gene Newsletter
-
10.06.26 -- Inside Scaling Next-Gen MSCs Without Scaling Risk
10/6/2026
10/06/26 Cell & Gene Newsletter
-
10.05.26 -- Enzyme Activity As A Surrogate Potency Marker In Cell Therapy
10/5/2026
10/05/26 Cell & Gene Newsletter
-
10.02.26 -- Building Sustainable Biopharma Supply Chains Starts With Procurement
10/2/2026
10/02/26 Cell & Gene Newsletter
-
10.01.26 -- New Podcast Episodes: 2026 Regulatory Updates, Funding A Virtual Biotech, Structuring CGT Deals
10/1/2026
10/01/26 Cell & Gene Newsletter
-
10.01.26 -- Building An End-To-End Strategy For CGT Manufacturing
10/1/2026
10/01/26 Cell & Gene Newsletter
-
10.01.26 -- Why CDMO Capacity Investments Signal A New Era In Cell & Gene
10/1/2026
10/01/26 Cell & Gene Newsletter
-
09.30.26 -- Fill/Finish Robotics Are Reshaping Aseptic Manufacturing
9/30/2026
09/30/26 Cell & Gene Newsletter
-
09.30.26 -- Modularity And Flexibility For Single-Use Biopharma Assemblies
9/30/2026
09/30/26 Cell & Gene Newsletter
-
09.30.26 -- Inside Kyverna's Autoimmune CAR T Platform Beyond SPS
9/30/2026
09/30/26 Cell & Gene Newsletter